*
Indexes: Dow down 0.3%, S&P 500 up 0.2%, Nasdaq up 0.6%
*
Kimberly-Clark to acquire Kenvue ( KVUE ) for about $48.7 bln
*
Iren jumps after $9.7 bln contract with Microsoft
*
U.S. manufacturing activity contracts in October
(Updates prices, analyst comment)
By Twesha Dikshit and Purvi Agarwal
Nov 3 2025 - The S&P 500 and Nasdaq edged higher on
Monday, after a slew of AI deals boosted megacap companies
Amazon ( AMZN ) and Nvidia ( NVDA ), while hawkish comments from Federal Reserve
officials kept optimism in check.
Amazon.com ( AMZN ) hit a record high after signing a
multi-year $38 billion deal to supply cloud computing services
to OpenAI, giving the ChatGPT maker access to Nvidia's ( NVDA ) graphics
processors.
Nvidia ( NVDA ) gained 3.2% after President Donald Trump
said the company's most advanced chips will be reserved for U.S.
companies and Microsoft secured export licenses to use its chips
in UAE data centers.
Loop Capital raised its price target for Nvidia ( NVDA ) stock by
$100, which also helped gains.
Optimism around AI has been driving markets to record highs
after several so-called "Magnificent Seven" companies pointed to
a surge in spending on the technology. The S&P 500 and the
Nasdaq marked their longest monthly winning streaks in years in
October.
Investors await results from Advanced Micro Devices ( AMD )
and Qualcomm ( QCOM ), among others this week.
"What's creeping in is this narrative about AI and when
business plans will be demonstrated to guide investors about
when they will see profits from the AI investments," said Peter
Andersen, founder of Andersen Capital Management.
"Those that are starting to think that the financing of
these deals, which are now being done off balance sheet in
special purpose vehicles, might be an early sign of the frailty
of financing these deals."
The consumer discretionary and information
technology sectors gained 1.7% and 0.6%, respectively,
kept the S&P 500 afloat. Most other sectors fell, with
financials the biggest drag.
Kenvue ( KVUE ) jumped 16.5% after Kimberly-Clark
said it will acquire the Tylenol maker in a deal valued at more
than $40 billion. Kimberly-Clark slid 12.5%.
At 11:54 a.m. ET, the Dow Jones Industrial Average
fell 186.25 points, or 0.39%, the S&P 500 gained 10.83
points, or 0.16% and the Nasdaq Composite gained 119.50
points, or 0.51%.
Healthcare heavyweights UnitedHealth Group ( UNH ) and Merck ( MRK )
fell 2.8% and 3%, respectively, weighing on the Dow.
PRIVATE ECONOMIC DATA AWAITED
Private sector economic data, including Wednesday's private
payrolls, will be closely watched this week, with the
second-longest U.S. government shutdown contributing to data fog
and monetary policy uncertainty.
Chicago Fed President Austan Goolsbee said on Monday he was
in no rush to cut interest rates again with inflation at high
levels, adding to recent hawkish commentary from other central
bank officials following a 25-basis-point cut last week.
Traders are now pricing in a 70.3% chance of a
25-basis-point rate cut in December, lower than the 90% a week
earlier, according to CME Group's FedWatch tool.
U.S. manufacturing contracted for an eighth consecutive
month in October as new orders remained subdued, data showed.
Meanwhile, the U.S. Supreme Court is set to hear a case
around the legality of Trump's tariffs on Wednesday.
IDEXX ( IDXX ) jumped 13% after raising its annual
forecasts, among the biggest gainers on the S&P 500.
Declining issues outnumbered advancers by a 1.86-to-1 ratio
on the NYSE and by a 1.88-to-1 ratio on the Nasdaq.
The S&P 500 posted 13 new 52-week highs and 29 new lows
while the Nasdaq Composite recorded 60 new highs and 146 new
lows.